Auteur L. MITCHESON

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users

J. McCAMBRIDGE ; A. WINSTOCK ; N. HUNT ; L. MITCHESON | 2007
Dans European Addiction Research (Vol.13, n°1, January 2007) Article : Périodique

AIMS: To describe and assess trends in the use of hallucinogens and other adjunct drugs over a 5-year period. DESIGN: Repeated-measures cross-sectional survey. SETTING AND PARTICIPANTS: Annual magazine-based survey targeting people who use drugs[...]

Plus d'info

Ajouter à la sélection

Extended-release buprenorphine treatment for opioid use disorder: A mixed-methods study of response and experience

N. LOWRY ; A. MCKECHNIE ; E. DAY ; E. GILVARRY ; F. COWDEN ; R. EVANS ; R. LOCKE ; R. MURRAY ; R. VANDERWAAL ; S. JOHNSTONE ; Z. HOARE ; M. KELLEHER ; L. MITCHESON ; J. MARSDEN | 2025
Dans Addiction (Vol.120, n°10, October 2025) Article : Périodique

BACKGROUND AND AIMS: An investigation of 24 weeks of extended-release buprenorphine (BUP-XR; Sublocade®) treatment for adults with opioid use disorder (OUD). Study aims were to characterise variations in clinical response, investigate personal f[...]

Plus d'info

Ajouter à la sélection

Lien externe

Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom

J. McCAMBRIDGE ; L. MITCHESON ; A. WINSTOCK ; N. HUNT | 2005
Dans Addiction (Vol.100, n°8, August 2005) Article : Périodique

Aims To describe and evaluate trends in the use of stimulant drugs over a 5-year period using an under-studied data collection method. Design Repeated-measures cross-sectional survey. Setting and participants Annual magazine-based survey targeti[...]

Plus d'info

Ajouter à la sélection

Lien externe

Has there been a decline in the prevalence of cannabis use among British nightclubbers ? Five-year survey data

J. McCAMBRIDGE ; N. HUNT ; A. WINSTOCK ; L. MITCHESON | 2005
Périodique

ENGLISH : Reductions in the prevalence and extent of current cannabis use among British nightclubbers have been reported in an annual survey conducted over the five years 19992003 inclusive. The generalizability and potential significance of t[...]

Plus d'info

Ajouter à la sélection

Mephedrone: use, subjective effects and health risks

A. WINSTOCK ; L. MITCHESON ; J. RAMSEY ; S. DAVIES ; M. PUCHNAREWICZ ; J. MARSDEN | 2011
Dans Addiction (Vol.106, n°11, November 2011) Article : Périodique

AIMS To assess the patterns of use, subjective effect profile and dependence liability of mephedrone, supported by corroborative urine toxicology. DESIGN Cross-sectional structured telephone interview. Setting UK-based drug users associated wi[...]

Plus d'info

Ajouter à la sélection

Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study

L. WIESSING ; M. FERRI ; V. BELACKOVA ; P. CARRIERI ; S. R. FRIEDMAN ; C. FOLCH ; K. DOLAN ; B. GALVIN ; P. VICKERMAN ; J. V. LAZARUS ; V. MRAVCIK ; M. KRETZSCHMAR ; V. SYPSA ; A. SARASA-RENEDO ; A. UUSKULA ; D. PARASKEVIS ; L. MENDAO ; D. ROSSI ; N. VAN GELDER ; L. MITCHESON ; L. PAOLI ; C. DIAZ GOMEZ ; M. MILHET ; N. DASCALU ; J. KNIGHT ; G. HAY ; E. KALAMARA ; R. SIMON ; C. M. COMISKEY ; C. ROSSI ; P. GRIFFITHS ; EUBEST working group | 2017
Dans Harm Reduction Journal (Vol.14, n°19, 2017) Article : Périodique

Background and aims: Despite advances in our knowledge of effective services for people who use drugs over the last decades globally, coverage remains poor in most countries, while quality is often unknown. This paper aims to discuss the histori[...]

Plus d'info

Ajouter à la sélection

Lien externe

New recreational drugs and the primary care approach to patients who use them

A. R. WINSTOCK ; L. MITCHESON | 2012
Dans British Medical Journal (Vol.344, n°7844, 18 February 2012) Article : Périodique

In recent years, hundreds of new drugs have appeared on the recreational drugs market in Europe. Some of these substances, such as ketamine and γ-hydroxybutyrate (GHB), have legitimate medical purposes. These compounds have been joined by many n[...]

Plus d'info

Ajouter à la sélection

Psychosocial interventions in opiate substitution treatment services: does the evidence provide a case for optimism or nihilism? [Addiction debate]

E. DAY, Auteur ; L. MITCHESON, Auteur ; P. M. FLYNN, Auteur du commentaire ; C. J. STRIKE ; A. GUTA ; J. SELIN ; D. RAISTRICK ; E. DAY ; L. MITCHESON, Auteur du commentaire | 2017
Dans Addiction (Vol.112, n°8, August 2017) Article : Périodique

Background and Aims: Clinical guidelines from around the world recommend the delivery of psychosocial interventions as part of routine care in opiate substitution treatment (OST) programmes. However, although individual studies demonstrate benef[...]

Plus d'info

Ajouter à la sélection

A review of the evidence-base for harm reduction approaches to drug use

N. HUNT ; M. ASHTON ; S. LENTON ; L. MITCHESON ; NELLES B. ; G. STIMSON | 2010
Rapport

'Harm reduction' is a term that is used to refer both to a set of general principles used to underpin policies concerning the way that societies respond to drug problems and, simultaneously, to some specific types of intervention, such as needle[...]

Plus d'info

Ajouter à la sélection

Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial

T. WEAVER ; N. METREBIAN ; J. HELLIER ; S. PILLING ; V. CHARLES ; N. LITTLE ; D. POOVENDRAN ; L. MITCHESON ; F. RYAN ; O. BOWDEN-JONES ; J. DUNN ; GLASPER A. ; E. FINCH ; J. STRANG | 2014
Dans Lancet (The) (Vol.384, n°9938, July 12, 2014) Article : Périodique

BACKGROUND. Poor adherence to treatment diminishes its individual and public health benefit. Financial incentives, provided on the condition of treatment attendance, could address this problem. Injecting drug users are a high-risk group for hepa[...]

Plus d'info

Ajouter à la sélection

Lien externe